论文信息 - The impact of cetuximab on the gemcitabine/cisplatin combination in first-line treatment of EGFR-positive advanced pancreatic cancer (APC): A randomized phase II trial of GISCAD - 字舞流文

The impact of cetuximab on the gemcitabine/cisplatin combination in first-line treatment of EGFR-positive advanced pancreatic cancer (APC): A randomized phase II trial of GISCAD

S. Barni | R. Labianca | L. Frontini | F. Costanzo | G. Tonini | R. Berardi | A. Zaniboni | S. Cascinu | S. Siena | A. Falcone | E. Aitini